NDC 51662-1375-01 - FAMOTIDINE
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 51662-1375
- Requested NDC
- 51662-1375-01
- Package NDCs from labels
- 51662-1375-1, 51662-1375-2, 51662-1375-01
- Manufacturer
- HF Acquisition Co LLC, DBA HealthFirst
- Effective date
- 2022-10-01
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| FAMOTIDINE - HF Acquisition Co LLC, DBA HealthFirst | HF Acquisition Co LLC, DBA HealthFirst | 2022-10-01 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 51662-1375-1 | FAMOTIDINE | 2 mL in 1 VIAL, SINGLE-DOSE | INJECTION, SOLUTION | 2 | 3 | |
| 51662-1375-2 | FAMOTIDINE | 1 in 1 POUCH | INJECTION, SOLUTION | 1 | 3 | |
| 51662-1375-2 | FAMOTIDINE | 2 mL in 1 VIAL, SINGLE-DOSE | INJECTION, SOLUTION | 2 | 3 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 51662-1375 | FAMOTIDINE INJECTION, SOLUTION [HF ACQUISITION CO LLC, DBA HEALTHFIRST] | 3 | Current NDC, Legacy NDC, 3 package rows | 20221002_9948991d-9405-c7c8-e053-2995a90a60ca.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Premasol - sulfite-free (Amino Acid) | LEUCINE, LYSINE, ISOLEUCINE, VALINE, HISTIDINE, PHENYLALANINE, THREONINE, METHIONINE, TRYPTOPHAN, TYROSINE, N-ACETYL-TYROSINE, ARGININE, PROLINE, ALANINE, GLUTAMIC ACIDE, SERINE, GLYCINE, ASPARTIC ACID, TAURINE, CYSTEINE HYDROCHLORIDE | Baxter Healthcare Company | 9afdcc3e-0d06-47f4-86ca-40da48b2b02b | 2022-08-04 | Boxed warning, Warnings, Adverse reactions | 30KYC7MIAI |
| signature care acid reducer complete | FAMOTIDINE, CALCIUM CARBONATE, MAGNESIUM HYDROXIDE | Safeway | 885f43ab-5c14-417b-aab7-e887dfc48f2e | 2022-07-20 | Warnings | 5QZO15J2Z8 |
| dg health acid reducer | FAMOTIDINE | Dolgencorp Inc | 3ffa405e-bc85-4614-afd0-7a8dfc288dad | 2022-07-13 | Warnings | 5QZO15J2Z8 |
| Dual Action Complete | FAMOTIDINE, CALCIUM CARBONATE AND MAGNESIUM HYDROXIDE | Kroger Company | 522a256b-a7c0-4783-bfff-3dc6b5a2b315 | 2022-07-12 | Warnings | 5QZO15J2Z8 |
| Equate Acid Reducer Complete | FAMOTIDINE, CALCIUM CARBONATE AND MAGNESIUM HYDROXIDE | Wal-Mart Stores Inc | 3400c3aa-15f2-4279-9623-72933298b3dd | 2022-07-12 | Warnings | 5QZO15J2Z8 |
| Basic Care Dual Action Complete | FAMOTIDINE, CALCIUM CARBONATE AND MAGNESIUM HYDROXIDE | Amazon.com Services LLC | 27235c87-2fe9-458f-8eb0-b9880199cd5a | 2022-07-11 | Warnings | 5QZO15J2Z8 |
| Famotidine | FAMOTIDINE | Proficient Rx LP | c84b0ba3-1ba8-4da9-b5b8-186e01cda999 | 2022-07-01 | Adverse reactions | 5QZO15J2Z8 |
| dg health heartburn prevention | FAMOTIDINE | Dolgencorp Inc | a8383769-ce8b-43eb-b1a6-5d73e7fcf30d | 2022-06-07 | Warnings | 5QZO15J2Z8 |
| Famotidine | FAMOTIDINE | Mylan Institutional LLC | e3b13e23-122b-4bd4-95cf-b5a14b7afc05 | 2022-06-01 | Warnings, Adverse reactions | 1743833 5QZO15J2Z8 |
| Famotidine | FAMOTIDINE | Proficient Rx LP | 68120de1-fd9a-4f93-b218-d99ed7c5080a | 2022-06-01 | Warnings | 5QZO15J2Z8 |
| Famotidine | FAMOTIDINE | Proficient Rx LP | 9baf2596-b771-4bae-a03c-d3af6716821d | 2022-05-02 | Adverse reactions | 5QZO15J2Z8 |
| Famotidine | FAMOTIDINE | Proficient Rx LP | 787724dc-0b4b-4973-852e-c7d722f637b0 | 2022-05-01 | Warnings | 5QZO15J2Z8 |
| Famotidine | FAMOTIDINE | Akorn | 354a5a02-45cb-4ab0-88ee-6635d5a43b01 | 2022-03-10 | Warnings, Adverse reactions | 5QZO15J2Z8 |
| FAMOTIDINE | FAMOTIDINE | Ascent Pharmaceuticals, Inc. | b481dd30-7d64-43ec-85d4-2289db62cad7 | 2022-02-14 | Warnings | 5QZO15J2Z8 |
| basic care acid reducer | FAMOTIDINE | Amazon.com Services LLC | 94fbcebe-7d75-47c1-9eca-cfa9b952a3d5 | 2022-01-06 | Warnings | 5QZO15J2Z8 |
| FAMOTIDINE | FAMOTIDINE | XLCare Pharmaceuticals, Inc. | 7b550cf9-221f-4f28-ba99-414ad7d5612f | 2021-12-10 | Warnings, Adverse reactions | 5QZO15J2Z8 |
| Famotidine | FAMOTIDINE | Camber Pharmaceuticals, Inc. | 902b5d4b-1707-4312-9f46-ef5ab86b00f0 | 2021-11-19 | Warnings, Adverse reactions | 5QZO15J2Z8 |
| Famotidine | FAMOTIDINE | Amneal Pharmaceuticals NY LLC | bb602b05-0ce6-4029-bd6e-291076e64efb | 2021-08-30 | Warnings, Adverse reactions | 5QZO15J2Z8 |
| Famotidine | FAMOTIDINE | Fresenius Kabi USA, LLC | ce533636-cc9b-45d0-87a6-5390377ff28a | 2021-07-15 | Warnings, Adverse reactions | ANDA075813 63323-739 1743833 241710d5-bcef-4852-a09c-0e681250e6aa ce533636-cc9b-45d0-87a6-5390377ff28a 5QZO15J2Z8 |
| Famotidine | FAMOTIDINE | Aphena Pharma Solutions - Tennessee, LLC | 46c6d243-eefc-40ca-8bd4-4c89456f635f | 2021-05-18 | Warnings, Adverse reactions | 5QZO15J2Z8 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.